(MedPage Today) — The FDA approved oral brensocatib (Brinsupri) as the first treatment for non-cystic fibrosis bronchiectasis in adults and kids 12 years and up, drugmaker Insmed announced on Tuesday.
A first-in-class reversible dipeptidyl peptidase…
Source link : https://www.medpagetoday.com/pulmonology/generalpulmonary/116965
Author :
Publish date : 2025-08-12 21:10:00
Copyright for syndicated content belongs to the linked Source.
